… The plasma Aβ40 biomarker was able to distinguish between AD and NC groups. However,
the plasma biomarkers in the present research were not able to distinguish between aMCI …

… To this end, we set out to determine which specific plasma biomarkers are important to
consider from a clinically available SIMOA Quanterix antibody assay consisting of Aβ42/40 ratio, p…

… with clinical AD are also associated with plasma biomarkers. This could help to further … ,
which the biomarkers represent. To that end, we measured plasma biomarkers in a sample of …

… Systematic Review: PubMed was searched for articles on plasma biomarkers of Alzheimer's
disease (AD) pathology. No article described fully automated assays implemented in clinical …

… Alzheimer's disease (AD) plasma biomarkers and confounding factors of associations between
plasma biomarkers … the importance of chronic kidney disease, no study has looked at the …

… plasma and traditional AD biomarkers, (2) assess the diagnostic accuracy of plasma biomarkers
as compared with traditional biomarkers, … saved thanks to the use of plasma biomarkers. …

… Using IP–MS, we originally developed a plasma biomarker that discriminated individuals …
by following the inclusion criteria of the Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2) …

… ► We assess patterns of biomarkers in blood for the diagnosis of Alzheimer's disease. ► …
into biomarkers. ► Studies in plasma and serum proteome, revealing potential biomarkers, are …

… In summary, the ADNI plasma biomarker data confirm CSF studies reporting increased
levels of PP, eotaxin 3, tenascin C, and NT-proBNP in patients with AD and MCI. When …

… In this study, we measure the plasma levels of Aβ40, Aβ42, p-tau181, t-tau, and … plasma
biomarkers and their CSF counterparts. Further, we evaluate the efficiency of plasma biomarkers …